Three common alleles determine six apolipoprotein E (apo E) phenotypes that are associated with variations in serum cholesterol in the population. This genetic variation results from single nucleotide alterations at two DNA loci encoding the amino acid residues 112 and 158 of apo E. We compared results of apo E phenotyping carried out by isoelectnc focusing with those of apo E genotyping accomplished by direct DNA analysis. In the latter, the target DNA was amplified by the polymerase chain reaction (PCR) and subsequently analyzed by digestion with the restriction enzyme Hha I, followed by polyacrylamide gel electrophoresis of the cleavage products. With one exception, these two techniques yielded similar results from all 40 samples tested. In addition, a rare variant form of apo E (phenotype El) was analyzed separately and incorrectly diagnosed as E2 by the Hha I digestion method; the anticipated mutation in the codon 127 was, however, confirmed by demonstration of a new Taq I restriction site in this variant gene. These data confirm that the common isoforms of apo E usually arise from genetic variation of the codons 112 and 158 and demonstrate the feasibility of the PCR technique in apo E genotyping.
Three common alleles determine six apolipoprotein E (apo E) phenotypes that are associated with variations in serum cholesterol in the population. This genetic variation results from single nucleotide alterations at two DNA loci encoding the amino acid residues 112 and 158 of apo E. We compared results of apo E phenotyping carried out by isoelectnc focusing with those of apo E genotyping accomplished by direct DNA analysis. In the latter, the target DNA was amplified by the polymerase chain reaction (PCR) and subsequently analyzed by digestion with the restriction enzyme Hha I, followed by polyacrylamide gel electrophoresis of the cleavage products. With one exception, these two techniques yielded similar results from all 40 samples tested. In addition, a rare variant form of apo E (phenotype El) was analyzed separately and incorrectly diagnosed as E2 by the Hha I digestion method; the anticipated mutation in the codon 127 was, however, confirmed by demonstration of a new Taq I restriction site in this variant gene. These data confirm that the common isoforms of apo E usually arise from genetic variation of the codons 112 and 158 and demonstrate the feasibility of the PCR technique in apo E genotyping.
Additional Keyphrases: hyperlipoproteinemia cholesterol risk factors Apolipoprotein E (apo E) is an important structural constituent of several serum lipoprotein classes, including VLDL (very-low-density lipeprotein), chylomicrons, and HDL (high-density lipoprotein). 6 It also serves as the ligand for LDL (low-density lipoprotein) and chylomicronremnant receptors (1) (2) (3) (4) . A recently described LDL-receptor-related protein, the function of which is still unknown, also appears to use ape E as a ligand (5). Aside from functioning in lipoprotein metabolism, apo E may be involved in the repair responses to tissue injury as well as in immunoregulation and modulation of cell growth (4) . Apo E is synthesized in most organs and cells of the body, especially in liver, brain, spleen, kidney, and macrophages (4) . The ape E structural gene, containing four exons and three introns, resides in chromosome 19 and codes for a mature ape E polypeptide of 299 amino acids (6) (7) (8) .
Three common isoforms of ape E (E2, E3, and E4), encoded by three different alleles (#{128}2, #{128}3, and #{128}4), exist in the population (2, 4 (37) . Apo E phenotyping.
Ape E phenotyping was carried out by analytical isoelectric focusing on polyacrylamide gel containing ultrapure urea, 8 mol/L, and 2% Ampholine, pH 4-6 (LKB, Bromma, Sweden). For subsequent immunoblotting we used commercially available rabbit anti-human ape E serum (Daiichi Pure Chemicals, Tokyo, Japan) (17) . We delipidated 4-10 L of serum with 6 mL of cold ethanol/ethyl ether (3/1 by vol), followed by 3 mL of ethanol/ethyl ether (3/2 by vol); we then dried the sample with ether. The proteins were dissolved in a solution of, per liter, 10 mmol of Tris, 8 mmol of urea, and 200 g of sucrose (pH 8.6). Isoelectric focusing and immunoblotting were then carried out by standard techniques described in detail previously (17) .
DNA amplification by the PCR. Leukocytic DNA was extracted from 10 mL of EDTA-anticoagulated whole blood according to Bell et al. (38) . We amplified a fragment of the fourth exon of the ape E gene in two steps, using two pairs of oligonucleotide primers (22-mers) designed on the basis of the known nucleotide sequence of the ape E gene (7), as follows: We labeled the oligonucleotides with {y-32P]dATP (Amersham, Bucks., U.K.), using T4 pelynucleotide kinase (40). Each of the four filters was hybridized for 20 h at 42 #{176}C in the solution described above, with one of the four labeled oligonucleotides.
After hybridization, all the filters were washed twice (5 mm each) at room temperature with a solution containing 0.3 mol of NaCl, 30 mmol of trisodium citrate, and 1 g of sodium dodecyl sulfate per liter. Using the same solution, we washed the filters for an additional 2 mm at the following temperatures:
probe 112-Cys, 67 #{176}C; probe 112-Arg, 73 #{176}C; probe 158-Cys, 61 #{176}C; and probe 158-Arg, 63 #{176}C. For autoradiography, the dried filters were exposed to Kodak-XAR film for 4-24 h at -70 #{176}C.
Results
The strategy of the ape E genotyping based on the H/ia I restriction fragment polymorphism of an amplified DNA fragment is illustrated in Figure 1 . During the PCR, the latter pair of amplification primers directs the generation of a DNA fragment 266 nucleotides long. This fragment contains four constant H/ia I sites (Figure 1) . In addition, H/ia I cleaves this fragment whenever a cleavage site (nucleotide sequence GCGC) occurs at codon 112 or 158, e.g., when this codon codes for arginine instead of cysteine.
We analyzed in three different ways six samples known to represent all the known ape E phenotypes (Figure 2 ). Slot-blot hybridization analysis with allele-specific oligonucleotide probes allowed easy identification of all possible combinations of the three alleles (Figure 2A) . In restriction analysis, each of the six genotypes yielded a characteristic restriction fragment pattern in addition to the constant fragments of 63, 18, and 16 bp (Figure 1 ). The small invariant 18-and 16-bp fragments were too small to be clearly visible in all analyses.
The e2/e2 genotype is characterized by the presence of the 91-and 78-bp fragments ( Figure 2B ). Because in this genotype no H/ia I cleavage sites are present at the two polymorphic sites, the 72-and 48-bp fragments are not formed. The genotype #{128}3/s2 shows an additional 48-bp fragment, whereas the genotype e3/e3 lacks the 78-bp fragment ( Figure 2B ). In the genotype e4Je2, a 72-bp fragment is formed, owing to the presence of the H/ia I cleavage site at position 112 (Figure 1 and Figure  2B ). In the genotype #{128}4/#{128}3, the 78-bp fragment is absent because both alleles have an argiine residue and thus an H/ia I cleavage site at position 158; however, a 91-bp fragment present in the a4/a3 genotype is, in turn, lacking in the genotype #{128}4/e4 ( Figure 2B ). The 48-and 30-hp fragments are faintly visible in the genotypes that have only one allele containing an argiine residue at position 158 (i.e., genotypes e3/e2 and #{128}4/#{128}2), but are more clearly present in the genotypes with a double dose of arginine at this position (i.e., e3/#{128}3, #{128}4/e3, and e4,e4) ( Figure 2B ). Figure 2C illustrates the results from an isoelectric focusing experiment for determining the ape E phenotypes from serum samples from the same individuals.
Aside from the panel of the six samples described above and analyzed by the three different techniques with ftilly congruent results, we determined the ape E genotypes and phenotypes by the H/ia I restriction fragment analysis and isoelectric focusing, respectively, in 40 unrelated individuals. According to the DNA analysis, 22 and one subject genotype #{128}4/e2. The calculated allele frequencies, based on DNA analysis, were 0.76,0.19, and 0.05 for #{128}3, #{128}4, and #{128}2, respectively. There was complete agreement between results of the two techniques except that one subject with the genotype #{128}3/#{128}3 (restriction site analysis) was phenotyped as E31E2 (isoelectric focusing). Blood samples were also obtained from a patient with a rare ape E phenotype, his spouse, and three children. Earlier studies showed that the patient's ape E isoelectric focusing pattern was characterized by two major bands, one in the E3 position and the other in the El position (34). Amino acid sequence analysis of the El variant suggested that it differed from E2 at residue 127 by an aspartic acid substituted for glycine, which agrees with the one-charge difference observed in isoelectric focusing (34). The codons for amino acid 126-128 in the normal ape E gene read as CTC GGC CAG (7) . Therefore, a Gly-.Asp mutation obligatorily implies a GGC-+GAC shift in codon 127, which would generate a new Taq I restriction site (recognition sequence TCGA) absent in the normal allele. Phenotyping by isoelectric focusing confirmed the presence of the abnormal ape E3/1 phenotype in the proband ( Figure 3A) . In this case, the H/ia I restriction analysis incorrectly suggested an e31e2 genotype ( Figure 3B ). However, as anticipated, the apparent #{128}2 allele of the patient could be distinguished from the normal #{128}2 allele by digestion of the amplified DNA, with the enzyme Taq I cleaving one of the patient's alleles into two pieces that were exactly the predicted size ( Figure 3C ; cf Figure 1 ). This experiment thus confirms the nature of the mutation behind the El phenotype. The mendelian inheritance of the mutant ape E allele was demonstrated by analysis of Taq I restriction fragment length polymorphism of the amplified DNA samples from the proband's family members (Figure 4) . Analysis of serum lipids confirmed the presence of hypertriglyceridemia in the father; the mother had moderate hypercholesterolemia, the cause of which is unknown (Table 1) . One of the children had hypertriglyceridemia, but this did not cosegregate with the abnormal ape E allele present in the family (Figure 4 and Table 1 ).
DiscussIon
Genetic polymorphism of ape E has considerable clinical significance because of the association of the #{128}4 allele with increased concentrations of LDL cholesterol in serum (14-B. 17) as well as susceptibility to atherosclerotic vascular disease (20) (21) (22) (23) (24) . In Finns, the impact of the ape E phenotype is even more pronounced because of the high frequency of #{128}4 allele (23% vs 15% in most other Western populations) and hypercholesterolemia and coronary artery disease in the population (17, 23) . In addition, the #{128}2 allele serves as a genetic marker for type Ill hyperlipeproteinemia. Although only a small percentage of individuals with the E2/2 phenotype actually express this disease, >90% of individuals with type ifi hyperlipeproteinemia have the E2/2 phenotype (3); thus, dietary or hormonal factors may be necessary for the development of the disease. Ape E phenotypes are routinely determined by use of two-dimensional gel electrophoresis (25) or isoelectric focusing combined with immunoblotting (26). However, these techniques do not permit an exact identification of the molecular alteration of the ape E gene. Methods for DNA analysis initially relied on the use of Southern blot technique, in which the different ape E genotypes were detected after gel electrophoresis with use of allele-specific oligonucleotide probes (41). Development of the PCR technique to amplify the relevant target DNA greatly improved the reliability of the direct ape E genotyping, and size fractionation of the total genomic DNA sample became unnecessary (29) (30) (31) (32) . The close proximity of the two variable DNA sites of the ape E gene fortunately allows their co-amplification within a single DNA fragment. We have recently introduced two novel detection strategies for ape E genotyping after the initial PCR amplification. In one (42), biotin is introduced into the 5'-ends of the DNA fragments synthesized during the PCR; the fragments are then captured on an avidin-matrix and directly sequenced on this solid support. This technique also permits identification of rare ape E variants caused by DNA mutations of the amino acids 110-160 (3, 4) ; however, it requires highly skilled personnel and facilities for DNA sequencing. In the second modification, the variable nucleotide in the biotinylated and immobilized DNA is identified by a one-step primer extension reaction directed by a detection step primer that anneals to the DNA immediately upstream of the site of variation (43). In this reaction a single labeled nucleoside triphosphate, complementary to the nucleotide at the variable site, is incorporated. This "mini-sequencing" technique is relatively simple to perform and sensitive enough to allow the use of even tritiated or nonradioactive markers (43). We also compared the genotyping by restriction enzyme digestion to the slot-blot hybridization technique (29) (30) (31) (32) , using the prechosen panel of samples with six different genotypes (Figure 2) . Although the latter system yielded identical results, it is technically more demanding, and even the slightest deviations of temperature during the final filterwashing step can produce erroneous results.
The disadvantage of the present PCR technique is that rare variants of the ape E gene can be misclassified as one of the normal alleles. Most variants reported are phenotype E2 and involve mutations clustered near residues 140-160 of the ape E molecule; typically, neutral amino acids are substituted for the basic residues arginine or lysine (for a review, see references 3, 4 (31) reported two structural mutants in addition to the common E2 form (Arg1-'Cys) among 100 #{128}2 alleles typed by electrophoresis and hybridization with allele-specific oligonucleotide probes. Weisgraber et al. (44) examined 34 ape E2/2 subjects and found all to have the common #{128}2 allele; however, one ape E3/3 control subject proved to have an abnormal #{128}3 allele, functionally equivalent to the #{128}2 allele.
The present study offers one additional example of ape E variants with disagreement between the phenotype and apparent genotype (Figure 3 ). Our investigation also confirms that this El phenotype (34) is due to a single nucleotide change in codon 127 of the ape E gene. The proband is clinically characterized by obesity, eruptive xanthomatosis, mild-to-moderate hypercholesterolemia, and profound hypertriglyceridemia, with no abnormalities of lipeprotein lipase, hepatic lipase, or apolipeprotein CII; the hyperlipidemia has been most responsive to dietary interventions (34). However, it remains unknown whether the hyperlipidemia of the proband is associated with the presenceof the El phenotype. In fact, this particular family showed no apparent relation between the occurrence of hyperlipidemia and the abnormal ape E allele (Table 1) . It is possible, however, that the phenotypic expression of the mutant ape E allele does not become manifest before adult life, which could explain the absence of hyperlipidemia in the son with this gene (Table 1) . This study provides a technique whereby the prevalence of this mutant allele in the general population as well as its occurrence among hyperlipidemic subjects can be investigated.
In conclusion, we developed a convenient modification of the PCR-based ape E genotyping techniques. The method is relatively easy to perform and does not require the use of radioisotopes. For routine purposes, it may even replace ape E phenotyping techniques, and for research applications, when combined with ape E phenotyping, it may be useful in the search for genetic heterogeneity among given ape E phenotypes.
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